ArticleCureus2022

Venetoclax and Azacitidine in the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory to Conventional Therapy.

Farhan Azad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.